Application 022332

Type
NDA
Sponsor
ELI LILLY CO

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ADCIRCATADALAFILTABLET;ORAL20MGYesYes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N022332-001ADCIRCATADALAFIL20MGTABLET / ORALAB2RLD, RS2009-05-22

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
N022332-001AB2

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-01 22:54:322026-06N022332-001ADCIRCA20MGTABLET / ORALAB2RLD, RS2009-05-22a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-01 22:54:322026-06N022332-001AB21a50c72e98297…

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ADCIRCATADALAFILUnited Therapeutics Corporationff61b237-be8e-461b-8114-78c52a8ad0ae2025-12-15Warnings, Adverse reactionsExact identifier
application applno (NDA): 022332
application number: NDA022332
ndc (product): 66302-467

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 8 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
43353-070ADCIRCATadalafilAphena Pharma Solutions - Tennessee, LLCNDACurrent
43353-070ADCIRCATadalafilAphena Pharma Solutions - Tennessee, LLCNDACurrent
66302-467ADCIRCATadalafilUnited Therapeutics CorporationNDACurrent
66302-467ADCIRCATadalafilUnited Therapeutics CorporationNDACurrent
66302-467ADCIRCATadalafilUnited Therapeutics CorporationNDACurrent
66302-467ADCIRCATadalafilUnited Therapeutics CorporationNDACurrent
66302-467ADCIRCATadalafilUnited Therapeutics CorporationNDACurrent
66302-467ADCIRCATadalafilUnited Therapeutics CorporationNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
64629SUPPL2020-09-21
64580SUPPL2020-09-16
48333SUPPL2017-05-09
48305SUPPL2017-05-09
17253SUPPL2015-04-07
7249SUPPL2015-04-03
17252SUPPL2014-05-02
29608SUPPL2014-04-30
29607SUPPL2013-11-25
38589SUPPL2013-11-22
7248SUPPL2011-02-14
38588SUPPL2011-02-09
21996ORIG2009-08-03
7247ORIG2009-05-29
17251ORIG2009-05-25